Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Congenital fibrosarcoma simulating congenital hemangioma.
Requena C, Miranda L, Cañete A, Almenar S, Nagore E, Llombart B, Sanmartín O, Botella R, Guillén C. Requena C, et al. Among authors: canete a. Pediatr Dermatol. 2008 Jan-Feb;25(1):141-4. doi: 10.1111/j.1525-1470.2007.00616.x. Pediatr Dermatol. 2008. PMID: 18304187 Review. No abstract available.
Neuroblastoma in Spain: Linking the national clinical database and epidemiological registries - A study by the Joint Action on Rare Cancers.
Cañete A, Peris-Bonet R, Capocaccia R, Pardo-Romaguera E, Segura V, Muñoz-López A, Fernández-Teijeiro A, Galceran-Padros J, Gatta G; Spanish Neuroblastoma Linkage Working Group (SpNbLinkWG). Cañete A, et al. Cancer Epidemiol. 2022 Jun;78:102145. doi: 10.1016/j.canep.2022.102145. Epub 2022 Mar 25. Cancer Epidemiol. 2022. PMID: 35344745 Free article.
miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis.
Berlanga P, Muñoz L, Piqueras M, Sirerol JA, Sánchez-Izquierdo MD, Hervás D, Hernández M, Llavador M, Machado I, Llombart-Bosch A, Cañete A, Castel V, Font de Mora J. Berlanga P, et al. Among authors: canete a. Mol Oncol. 2016 Aug;10(7):1043-53. doi: 10.1016/j.molonc.2016.04.004. Epub 2016 Apr 23. Mol Oncol. 2016. PMID: 27155790 Free PMC article.
A comparison of current neuroblastoma chemotherapeutics.
Castel V, Cañete A. Castel V, et al. Among authors: canete a. Expert Opin Pharmacother. 2004 Jan;5(1):71-80. doi: 10.1517/14656566.5.1.71. Expert Opin Pharmacother. 2004. PMID: 14680437 Review.
Advances in emerging drugs for the treatment of neuroblastoma.
Berlanga P, Cañete A, Castel V. Berlanga P, et al. Among authors: canete a. Expert Opin Emerg Drugs. 2017 Mar;22(1):63-75. doi: 10.1080/14728214.2017.1294159. Epub 2017 Feb 22. Expert Opin Emerg Drugs. 2017. PMID: 28253830 Review.
Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition.
Sanmartín E, Muñoz L, Piqueras M, Sirerol JA, Berlanga P, Cañete A, Castel V, Font de Mora J. Sanmartín E, et al. Among authors: canete a. Clin Cancer Res. 2017 Nov 15;23(22):6875-6887. doi: 10.1158/1078-0432.CCR-17-0593. Epub 2017 Aug 22. Clin Cancer Res. 2017. PMID: 28830922
193 results